Project Grant HT94252310540
Award Date
8/1/23
Completion Date
7/31/27
Dollars Obligated
$1.5M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Rootstown, OH 44272, USA
Similar Awards
This $1,199,967 Project Grant awarded on September 1, 2023 by the Defense Health Agency supports research under the Military Medical Research and Development (CFDA 12.420) program. The primary award recipient, the University of Vermont & State Agricultural College, will investigate "Cognitive Functions Impairment as a Novel Paradigm for Delineating Cognitive Dysfunction in Parkinson's Disease". Two sub-awards were made to Case Western Reserve University and the Portland VA Research...
The federal Project Grant award, valued at $2,000,000.00 and effective from June 1, 2025 to May 31, 2028, was issued by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award will support research by the University of Nebraska Medical Center (UNMC) to investigate the interrelationship between disruption in the PINK1-PRKN pathway and tauopathy, and their role in the pathophysiology of cognitive impairment in Parkinson's disease. The...
The Cleveland Clinic Foundation will receive $400,000 from the Defense Health Agency under a two-year Project Grant award through the Military Medical Research and Development program (CFDA 12.420). The grant will support research from July 1, 2023 to June 30, 2025 to investigate the role of microglia and the NLRP3 inflammasome in contributing to non-motor deficits associated with Parkinson's disease. The Military Medical Research and Development program aims to transform military and public...
The University of Toledo received a $1.7 million project grant award from the Defense Health Agency on September 15, 2021 to complete work by August 14, 2025. The grant is part of the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform military and public health care. Specifically, the University will investigate maladaptive nigrovagal pathophysiology in parkinsonism under this award. The research aims to...
This Project Grant award from the Defense Health Agency provides $1,499,699.00 to Michigan State University to conduct research on "MODELING COGNITIVE DYSFUNCTION IN PARKINSON'S DISEASE AND THE IMPACT OF EXERCISE" from August 1, 2023 to July 31, 2027. The research is funded under the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform healthcare for Service Members and the American public. As part...
This federal Project Grant award of $1,021,409.00 from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program will support research at the University of Illinois to investigate the underlying neurobiology of non-motor symptoms in Parkinson's disease. The research aims to elucidate the role of serotonin system plasticity in the development of these disabling non-motor complications, which can include cognitive, psychiatric, and...
The Defense Health Agency awarded a $1,493,220 Project Grant to The Cleveland VA Medical Research & Education Foundation under the Military Medical Research and Development program (CFDA 12.420). The grant supports the development of a "Neurally Integrated Lower Limb Prosthesis for Home and Community Use" to aid mobility and sensory restoration for wounded veterans. The 4-year project, running from September 2023 to August 2027, aligns with the program's priorities of advancing...
This federal Project Grant award, with a total funding amount of $749,049.00, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant is supporting advanced biomedical research at Northeastern University in Boston, Massachusetts, focused on "ADVANCING OVERLOAD PREDICTION AND PROTECTION IN BONE-ANCHORED LIMBS". The research aims to transform healthcare for military service members and the broader public...
This $249,960 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research conducted by The Ohio State University to investigate the effects of the aged inflammatory central nervous system (CNS) microenvironment on oligodendroglial properties and remyelination capacity. The research aims to advance scientific understanding of age-related changes in the CNS that can impact myelin repair, with potential applications for...
The Pennsylvania State University College of Medicine received a $1.29 million project grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The four-year award will fund research into maladaptive nigrovagal pathophysiology in parkinsonism. Through September 2025, the university will investigate medical solutions for neurological conditions affecting service members and veterans, with the goal of transforming...